SOUTH SAN FRANCISCO, Calif., Dec. 01, 2021 (GLOBE NEWSWIRE) — Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on November 30, 2021 it granted stock options to purchase an aggregate of 143,500 shares of common stock to 9 new employees, whose employment commenced in November 2021, as a material inducement to […]
Financial
Qardio Names Mike Alvarez as President and Chief Executive Officer
Former Medtronic Executive Brings Significant Experience in Cardiac and Remote Patient Monitoring to Help Deliver Qardio’s Mission to Transform Cardiac and Chronic Care AMSTERDAM & SAN FRANCISCO–(BUSINESS WIRE)–Qardio, Inc. (“Qardio” or “Company”), a medical technology company that operates at the intersection of cardiology and remote patient monitoring, today announced the Company’s […]
Calroy Health Sciences Establishes Science and Medical Advisory Board
Clinical, science, and natural products industry experts to advance Company’s research, clinical studies, and product development strategies SCOTTSDALE, Ariz.–(BUSINESS WIRE)–Calroy Health Sciences, a company dedicated to developing innovative natural solutions to optimize cardiovascular health, today announced the establishment of a science and medical advisory board comprised of leading researchers and […]
BioSig Technologies, Inc. Appoints Gray Fleming as Chief Commercial Officer
Seasoned electrophysiology sales executive joins the Company to expand the commercial footprint of its signal processing technology for arrhythmia care Westport, CT, Dec. 01, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve […]
Munich Re, Canada (Life) and Heart & Stroke Join Forces in the Fight Against Cardiovascular Disease
Commence a strategic partnership to advance women’s heart and brain health through awareness and prevention TORONTO–(BUSINESS WIRE)–Munich Reinsurance Company’s Canadian life branch (Munich Re) today announced a strategic partnership with Heart & Stroke reinforcing its commitment to combatting cardiovascular disease. With this partnership, Munich Re will provide financial support for […]
BD Names Dr. Joseph M. Smith as Chief Scientific Officer
Digital Health Pioneer to Focus on External Innovation; Becomes Co-Chair of BD Scientific Advisory Board FRANKLIN LAKES, N.J., Nov. 29, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific officer for the […]
Verve Therapeutics Appoints Allison Dorval, Experienced Financial Executive, as Chief Financial Officer
CAMBRIDGE, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) — Verve Therapeutics, Inc., (Nasdaq: VERV), a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced that Allison Dorval has been appointed as chief financial officer. Ms. Dorval joins Verve from Voyager Therapeutics and […]
NorthStar Medical Radioisotopes Expands Management Team with Appointment of Adam Lynch as Vice President, Corporate Development and External Affairs
BELOIT, Wis.–(BUSINESS WIRE)–NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, today announced the appointment of Adam D. Lynch as Vice President, Corporate Development and External Affairs. In this new position, he brings to the Company more […]
Neovasc Granted Additional 180 Calendar Day Grace Period for Nasdaq Bid Price Compliance
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) has received written notification (the “Nasdaq Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that in accordance with Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq has granted an additional 180 calendar day […]
EBR Systems Raises AU$110M in Initial Public Offering on the Australian Securities Exchange (ASX)
EBR Systems’ WiSE™ CRT System is world’s first and only wireless endocardial (inside the heart) left ventricle pacing system for heart failure EBR’s AU$110m ASX initial public offering today was strongly supported by new and existing institutional shareholders The new capital funds the completion of pivotal study, targeting FDA submission for approval […]



